Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study. (Q43260540)
Jump to navigation
Jump to search
scientific article published on 15 October 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study. |
scientific article published on 15 October 2009 |
Statements
Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study (English)
A Sankowski
N Seklecka
J R Buscombe
A Nasierowska-Guttmejer
R Mikolajczak
D Pawlak
K Stepien
15 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference